ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, cilt.24, ss.585-593, 2015 (SCI İndekslerine Giren Dergi)
Background. Cisplatin, an effective chemotherapeutic agent, is used for the treatment of several types of cancers. However, cisplatin has some severe side effects such as nephrotoxicity. On the other hand, molsidomine, a NO donor, has anti-oxidative and vasodilator effects.